9wcy

Cryo-EM structure of the Mycobacterium abscessus cytochrome bcc:aa3 supercomplex in the presence of ND-011458

spinqualitylabelsall models 9wcy, resolution 2.26Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Structural highlights 9wcy is a 20 chain structure with sequence from Mycobacteroides abscessus. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance. Method: Electron Microscopy, Resolution 2.26Å Ligands: 9XX, 9Y0, 9YF, A1MBF, CDL, CU, FES, HEA, HEC, HEM, MQ9, OXY, PLM Resources: FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT Function B1MDZ6_MYCA9 Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Subunits 1-3 form the functional core of the enzyme complex. CO I is the catalytic subunit of the enzyme. Electrons originating in cytochrome c are transferred via the copper A center of subunit 2 and heme A of subunit 1 to the bimetallic center formed by heme A3 and copper B.[ARBA:ARBA00025218][RuleBase:RU363061] Publication Abstract from PubMed The cytochrome bcc:aa(3) oxidase is the target of telacebec, a clinically advanced drug developed for Mycobacterium tuberculosis. However, telacebec is inactive against Mycobacterium abscessus, an opportunistic pathogen increasingly linked to chronic pulmonary infections and notoriously known for intrinsic resistance to numerous antibiotics. Here, we report the 2.6 A cryo-electron microscopy structure of the M. abscessus bcc:aa(3) cytochrome oxidase supercomplex, revealing key pathways and the evolution of the mycobacterial QcrB menaquinol-binding cavity. Structure-guided mutagenesis identified polymorphisms that modulate telacebec binding and potency in both M. abscessus and Mycobacterium smegmatis. Leveraging these insights, we designed ND-011458, a QcrB inhibitor with potent activity against M. abscessus and being bactericidal in combination with Clofazimine. The 2.26 A inhibitor-bound structure elucidates its binding mode and provides a framework for the design of next-generation inhibitors for M. abscessus pulmonary diseases. The Mycobacterium abscessus cytochrome bcc:aa(3) oxidase structure paves the way for an agent targeting subunit QcrB.,Mathiyazakan V, Tan EXY, Moraski G, Basak S, Saw WG, Pethe K, Gruber G Nat Commun. 2026 Apr 3;17(1):4821. doi: 10.1038/s41467-026-70805-5. PMID:41932870 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Proteopedia Page Contributors and Editors (what is this?)

OCA